G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 993.9 INR -1.91% Market Closed
Market Cap: 121.8B INR
Have any thoughts about
Glenmark Life Sciences Ltd?
Write Note

Income Statement

Earnings Waterfall
Glenmark Life Sciences Ltd

Revenue
22B INR
Cost of Revenue
-9.9B INR
Gross Profit
12.1B INR
Operating Expenses
-6.6B INR
Operating Income
5.5B INR
Other Expenses
-1.3B INR
Net Income
4.2B INR

Income Statement
Glenmark Life Sciences Ltd

Rotate your device to view
Income Statement
Currency: INR
Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
18 852
N/A
29 309
+55%
29 718
+1%
20 763
-30%
21 232
+2%
20 882
-2%
20 357
-3%
20 540
+1%
21 612
+5%
22 498
+4%
23 359
+4%
23 679
+1%
22 832
-4%
22 934
+0%
22 049
-4%
Gross Profit
Cost of Revenue
(9 055)
(14 588)
(14 361)
(9 802)
(10 429)
(10 124)
(9 812)
(9 888)
(10 141)
(10 332)
(10 663)
(10 437)
(10 020)
(10 418)
(9 939)
Gross Profit
9 797
N/A
14 720
+50%
15 357
+4%
10 961
-29%
10 803
-1%
10 758
0%
10 546
-2%
10 651
+1%
11 471
+8%
12 166
+6%
12 695
+4%
13 242
+4%
12 812
-3%
12 516
-2%
12 110
-3%
Operating Income
Operating Expenses
(4 176)
(6 394)
(6 620)
(4 792)
(5 011)
(4 920)
(4 868)
(4 960)
(5 427)
(5 514)
(5 941)
(6 308)
(6 591)
(6 663)
(6 604)
Selling, General & Administrative
(3 846)
(2 286)
(2 346)
(1 671)
(4 635)
(1 722)
(1 710)
(1 754)
(4 787)
(1 879)
(2 072)
(2 297)
(5 761)
(2 669)
(2 626)
Depreciation & Amortization
(334)
(507)
(520)
(367)
(379)
(388)
(391)
(401)
(421)
(448)
(480)
(504)
(535)
(552)
(572)
Other Operating Expenses
4
(3 602)
(3 754)
(2 753)
3
(2 809)
(2 767)
(2 804)
(218)
(3 187)
(3 389)
(3 506)
(296)
(3 442)
(3 406)
Operating Income
5 621
N/A
8 326
+48%
8 738
+5%
6 169
-29%
5 792
-6%
5 838
+1%
5 677
-3%
5 692
+0%
6 045
+6%
6 652
+10%
6 754
+2%
6 935
+3%
6 221
-10%
5 853
-6%
5 507
-6%
Pre-Tax Income
Interest Income Expense
(905)
(1 300)
(1 153)
(490)
(135)
(75)
(5)
(6)
283
(8)
(11)
(13)
99
(15)
(14)
Non-Reccuring Items
0
0
0
0
0
0
0
0
(37)
0
0
0
0
0
0
Gain/Loss on Disposition of Assets
(6)
0
0
0
(7)
0
0
0
(6)
0
0
0
(7)
0
0
Total Other Income
(1)
0
0
0
(1)
0
0
0
1
0
54
71
(0)
157
188
Pre-Tax Income
4 709
N/A
7 026
+49%
7 584
+8%
5 679
-25%
5 649
-1%
5 762
+2%
5 673
-2%
5 686
+0%
6 286
+11%
6 644
+6%
6 797
+2%
6 992
+3%
6 313
-10%
5 995
-5%
5 681
-5%
Net Income
Tax Provision
(1 194)
(1 776)
(1 907)
(1 434)
(1 462)
(1 497)
(1 490)
(1 491)
(1 616)
(1 707)
(1 742)
(1 799)
(1 604)
(1 526)
(1 446)
Income from Continuing Operations
3 516
5 250
5 677
4 245
4 187
4 265
4 182
4 195
4 670
4 937
5 055
5 193
4 709
4 469
4 235
Net Income (Common)
3 516
N/A
5 250
+49%
5 677
+8%
4 245
-25%
4 187
-1%
4 265
+2%
4 182
-2%
4 195
+0%
4 670
+11%
4 937
+6%
5 055
+2%
5 193
+3%
4 709
-9%
4 469
-5%
4 235
-5%
EPS (Diluted)
28.69
N/A
48.69
+70%
48.39
-1%
35.4
-27%
35.63
+1%
34.79
-2%
34.12
-2%
34.24
+0%
38.11
+11%
40.29
+6%
41.26
+2%
42.28
+2%
38.38
-9%
36.41
-5%
34.43
-5%

See Also

Discover More